MBM Wealth Consultants LLC Buys 270 Shares of The Cigna Group (NYSE:CI)

MBM Wealth Consultants LLC increased its stake in shares of The Cigna Group (NYSE:CI) by 7.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,885 shares of the health services provider’s stock after acquiring an additional 270 shares during the quarter. MBM Wealth Consultants LLC’s holdings in The Cigna Group were worth $1,066,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CI. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the 4th quarter valued at approximately $34,000. Ulland Investment Advisors LLC increased its holdings in shares of The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group during the 3rd quarter valued at about $37,000. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group in the 3rd quarter valued at about $45,000. Finally, Intact Investment Management Inc. purchased a new position in The Cigna Group in the third quarter worth about $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Trading Up 1.6 %

NYSE:CI opened at $288.48 on Wednesday. The firm has a 50-day simple moving average of $300.19 and a 200-day simple moving average of $326.51. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The firm has a market cap of $80.24 billion, a P/E ratio of 27.21, a P/E/G ratio of 0.77 and a beta of 0.54. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter in the previous year, the firm posted $6.77 earnings per share. The Cigna Group’s revenue for the quarter was up 29.8% compared to the same quarter last year. Equities analysts anticipate that The Cigna Group will post 28.5 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently issued reports on CI. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Piper Sandler restated an “overweight” rating and issued a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Royal Bank of Canada cut their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Barclays increased their price target on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $395.93.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.